Form4insider filings, from the source

SEC Form 4 · accession 0000874015-15-000023

IONIS PHARMACEUTICALS INC · IONS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
B Lynne Parshall
Officer — COO & Secretary · Director
Period of report
Jan 15, 2015
Accepted (ET)
Jan 20, 2015 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 15, 2015M1,715$0.00A6,132D
Common StockF2Jan 16, 2015S903$67.964D5,229D
Common StockF3Jan 15, 2015M2,595$0.00A7,824D
Common StockF4Jan 16, 2015S1,372$67.964D6,452D
Common StockF5Jan 15, 2015M3,438$0.00A9,890D
Common StockF6Jan 16, 2015S1,818$67.964D8,072D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF7,F8—Jan 15, 2015A22,076A——Common Stock22,07622,076D
Restricted Stock UnitsF2,F7,F9—Jan 15, 2015M1,715D——Common Stock1,7151,715D
Restricted Stock UnitsF4,F7,F10—Jan 15, 2015M2,595D——Common Stock2,5955,190D
Restricted Stock UnitsF6,F7,F11—Jan 15, 2015M3,438D——Common Stock3,43810,312D

Explanation of responses